References
Lupardus PJ, Ultsch M, Wallweber H et al (2014) Structure of the pseudokinase-kinase domains from protein kinase TYK2 reveals a mechanism for Janus kinase (JAK) autoinhibition. Proc Natl Acad Sci U S A 111:8025–8030
Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, Kondrashov AS (2010) Sunyaev SR. Nat Methods 7(4):248–249
Canté-Barrett K, Uitdehaag JC, Meijerink JP (2016) Structural modeling of JAK1 mutations in T-cell acute lymphoblastic leukemia reveals a second contact site between pseudokinase and kinase domains. Haematologica 101(5):e189–e191
Perez C, Gonzalez-Rincon J, Onaindia A et al (2015) Mutated JAK kinases and deregulated STAT activity are potential therapeutic targets in cutaneous T-cell lymphoma. Haematologica 100(11):e450–e453
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Stein, M.K., Morris, L.K. & Martin, M.G. JAK Pseudokinase Domain Variants Highlight nRTK VUSs Identified with Next-Generation Sequencing in Solid Tumor Patients. Pathol. Oncol. Res. 25, 817–818 (2019). https://doi.org/10.1007/s12253-018-0443-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12253-018-0443-3